Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$9.23 - $22.43 $88,737 - $215,642
-9,614 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$14.86 - $23.55 $37,239 - $59,016
-2,506 Reduced 20.68%
9,614 $200,000
Q4 2021

Feb 08, 2022

BUY
$19.99 - $30.24 $242,278 - $366,508
12,120 New
12,120 $280,000
Q3 2021

Nov 12, 2021

SELL
$26.84 - $36.58 $182,619 - $248,890
-6,804 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$28.01 - $36.01 $190,580 - $245,012
6,804 New
6,804 $232,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $64.8M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.